Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA.
Sci Transl Med. 2017 May 31;9(392):eaaf6295. doi: 10.1126/scitranslmed.aaf6295.
C3 Deficiency Leads to Increased Angiogenesis and Elevated Pro-Angiogenic Leukocyte Recruitment in Ischemic Muscle Tissue.
Götz P, Braumandl A, Kübler M, Kumaraswami K, Ishikawa-Ankerhold H, Lasch M, Deindl E.
Int J Mol Sci. 2021 May 28;22(11):5800. doi: 10.3390/ijms22115800.
Complement C3 deficiency: human, animal, and experimental models.
Singer L, Colten HR, Wetsel RA.
Pathobiology. 1994;62(1):14-28. doi: 10.1159/000163873.
Case Report: C3 deficiency in two siblings.
Bernacchia A, Ginaca A, Rotondo S, Tejada MP, Di Giovanni D.
Front Pediatr. 2024 Jul 24;12:1424380. doi: 10.3389/fped.2024.1424380. eCollection 2024.
Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
Vernon KA, Ruseva MM, Cook HT, Botto M, Malik TH, Pickering MC.
J Am Soc Nephrol. 2016 May;27(5):1334-42. doi: 10.1681/ASN.2015030295. Epub 2015 Sep 15.
An inherited deficiency of the third component of complement, C3, in guinea pigs.
Burger R, Gordon J, Stevenson G, Ramadori G, Zanker B, Hadding U, Bitter-Suermann D.
Eur J Immunol. 1986 Jan;16(1):7-11. doi: 10.1002/eji.1830160103.
Complement C3 and C5 deficiency affects fracture healing.
Ehrnthaller C, Huber-Lang M, Nilsson P, Bindl R, Redeker S, Recknagel S, Rapp A, Mollnes T, Amling M, Gebhard F, Ignatius A.
PLoS One. 2013 Nov 18;8(11):e81341. doi: 10.1371/journal.pone.0081341. eCollection 2013.
C3 deficiencies.
Bitter-Suermann D, Burger R.
Curr Top Microbiol Immunol. 1990;153:223-33. doi: 10.1007/978-3-642-74977-3_12.
Influence of C3 deficiency on atherosclerosis.
Buono C, Come CE, Witztum JL, Maguire GF, Connelly PW, Carroll M, Lichtman AH.
Circulation. 2002 Jun 25;105(25):3025-31. doi: 10.1161/01.cir.0000019584.04929.83.
Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
Alper CA, Colten HR, Gear JS, Rabson AR, Rosen FS.
J Clin Invest. 1976 Jan;57(1):222-9. doi: 10.1172/JCI108263.
